annual CAPEX:
$498.00M-$28.00M(-5.32%)Summary
- As of today (May 29, 2025), TEVA annual capital expenditures is $498.00 million, with the most recent change of -$28.00 million (-5.32%) on December 31, 2024.
- During the last 3 years, TEVA annual CAPEX has fallen by -$64.00 million (-11.39%).
- TEVA annual CAPEX is now -54.89% below its all-time high of $1.10 billion, reached on December 31, 2012.
Performance
TEVA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$127.00M-$2.00M(-1.55%)Summary
- As of today (May 29, 2025), TEVA quarterly capital expenditures is $127.00 million, with the most recent change of -$2.00 million (-1.55%) on March 31, 2025.
- Over the past year, TEVA quarterly CAPEX has increased by +$3.00 million (+2.42%).
- TEVA quarterly CAPEX is now -61.86% below its all-time high of $333.00 million, reached on December 31, 2016.
Performance
TEVA quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$501.00M+$3.00M(+0.60%)Summary
- As of today (May 29, 2025), TEVA TTM capital expenditures is $501.00 million, with the most recent change of +$3.00 million (+0.60%) on March 31, 2025.
- Over the past year, TEVA TTM CAPEX has dropped by -$10.00 million (-1.96%).
- TEVA TTM CAPEX is now -55.31% below its all-time high of $1.12 billion, reached on June 30, 2012.
Performance
TEVA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TEVA CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -5.3% | +2.4% | -2.0% |
3 y3 years | -11.4% | -19.1% | -11.9% |
5 y5 years | -5.1% | -0.8% | -5.1% |
TEVA CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -11.4% | at low | -19.1% | +30.9% | -14.1% | +2.7% |
5 y | 5-year | -13.8% | at low | -27.8% | +30.9% | -16.5% | +2.7% |
alltime | all time | -54.9% | +2133.2% | -61.9% | +443.1% | -55.3% | +2042.6% |
TEVA CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $127.00M(-1.6%) | $501.00M(+0.6%) |
Dec 2024 | $498.00M(-5.3%) | $129.00M(-12.8%) | $498.00M(+2.0%) |
Sep 2024 | - | $148.00M(+52.6%) | $488.00M(-0.2%) |
Jun 2024 | - | $97.00M(-21.8%) | $489.00M(-4.3%) |
Mar 2024 | - | $124.00M(+4.2%) | $511.00M(-2.9%) |
Dec 2023 | $526.00M(-4.0%) | $119.00M(-20.1%) | $526.00M(-4.2%) |
Sep 2023 | - | $149.00M(+25.2%) | $549.00M(+5.2%) |
Jun 2023 | - | $119.00M(-14.4%) | $522.00M(-1.5%) |
Mar 2023 | - | $139.00M(-2.1%) | $530.00M(-3.3%) |
Dec 2022 | $548.00M(-2.5%) | $142.00M(+16.4%) | $548.00M(-2.0%) |
Sep 2022 | - | $122.00M(-3.9%) | $559.00M(-4.1%) |
Jun 2022 | - | $127.00M(-19.1%) | $583.00M(+2.5%) |
Mar 2022 | - | $157.00M(+2.6%) | $569.00M(+1.2%) |
Dec 2021 | $562.00M(-2.8%) | $153.00M(+4.8%) | $562.00M(-3.9%) |
Sep 2021 | - | $146.00M(+29.2%) | $585.00M(+0.5%) |
Jun 2021 | - | $113.00M(-24.7%) | $582.00M(-3.0%) |
Mar 2021 | - | $150.00M(-14.8%) | $600.00M(+3.8%) |
Dec 2020 | $578.00M(+10.1%) | $176.00M(+23.1%) | $578.00M(+10.9%) |
Sep 2020 | - | $143.00M(+9.2%) | $521.00M(-4.8%) |
Jun 2020 | - | $131.00M(+2.3%) | $547.00M(+3.6%) |
Mar 2020 | - | $128.00M(+7.6%) | $528.00M(+0.6%) |
Dec 2019 | $525.00M(-19.4%) | $119.00M(-29.6%) | $525.00M(-15.2%) |
Sep 2019 | - | $169.00M(+50.9%) | $619.00M(+5.1%) |
Jun 2019 | - | $112.00M(-10.4%) | $589.00M(-3.9%) |
Mar 2019 | - | $125.00M(-41.3%) | $613.00M(-5.8%) |
Dec 2018 | $651.00M(-25.5%) | $213.00M(+53.2%) | $651.00M(-7.7%) |
Sep 2018 | - | $139.00M(+2.2%) | $705.00M(-9.4%) |
Jun 2018 | - | $136.00M(-16.6%) | $778.00M(-6.8%) |
Mar 2018 | - | $163.00M(-39.0%) | $835.00M(-4.5%) |
Dec 2017 | $874.00M(-3.0%) | $267.00M(+25.9%) | $874.00M(-7.0%) |
Sep 2017 | - | $212.00M(+9.8%) | $940.00M(-0.9%) |
Jun 2017 | - | $193.00M(-4.5%) | $949.00M(+1.9%) |
Mar 2017 | - | $202.00M(-39.3%) | $931.00M(+3.3%) |
Dec 2016 | $901.00M(+16.7%) | $333.00M(+50.7%) | $901.00M(+10.4%) |
Sep 2016 | - | $221.00M(+26.3%) | $816.00M(+6.7%) |
Jun 2016 | - | $175.00M(+1.7%) | $765.00M(+0.8%) |
Mar 2016 | - | $172.00M(-30.6%) | $759.00M(-1.7%) |
Dec 2015 | $772.00M(-16.9%) | $248.00M(+45.9%) | $772.00M(-6.3%) |
Sep 2015 | - | $170.00M(+0.6%) | $824.00M(-4.8%) |
Jun 2015 | - | $169.00M(-8.6%) | $866.00M(-2.6%) |
Mar 2015 | - | $185.00M(-38.3%) | $889.00M(-4.3%) |
Dec 2014 | $929.00M(-9.9%) | $300.00M(+41.5%) | $929.00M(-1.5%) |
Sep 2014 | - | $212.00M(+10.4%) | $943.00M(-1.7%) |
Jun 2014 | - | $192.00M(-14.7%) | $959.00M(-3.3%) |
Mar 2014 | - | $225.00M(-28.3%) | $992.00M(-3.8%) |
Dec 2013 | $1.03B(-6.6%) | $314.00M(+37.7%) | $1.03B(-1.2%) |
Sep 2013 | - | $228.00M(+1.3%) | $1.04B(-2.0%) |
Jun 2013 | - | $225.00M(-14.8%) | $1.06B(-2.7%) |
Mar 2013 | - | $264.00M(-19.3%) | $1.09B(-0.9%) |
Dec 2012 | $1.10B(+4.8%) | $327.00M(+31.3%) | $1.10B(+0.9%) |
Sep 2012 | - | $249.00M(-2.0%) | $1.09B(-2.4%) |
Jun 2012 | - | $254.00M(-7.3%) | $1.12B(+2.6%) |
Mar 2012 | - | $274.00M(-13.6%) | $1.09B(+3.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $1.05B(+48.3%) | $317.00M(+14.9%) | $1.05B(+8.6%) |
Sep 2011 | - | $276.00M(+22.1%) | $970.00M(+11.6%) |
Jun 2011 | - | $226.00M(-3.4%) | $869.00M(+11.6%) |
Mar 2011 | - | $234.00M(0.0%) | $779.00M(+9.7%) |
Dec 2010 | $710.00M(-1.3%) | $234.00M(+33.7%) | $710.00M(+3.2%) |
Sep 2010 | - | $175.00M(+28.7%) | $688.00M(-3.0%) |
Jun 2010 | - | $136.00M(-17.6%) | $709.00M(-19.8%) |
Mar 2010 | - | $165.00M(-22.2%) | $884.00M(+22.9%) |
Dec 2009 | $719.00M(+5.6%) | $212.00M(+8.2%) | $719.00M(+4.5%) |
Sep 2009 | - | $196.00M(-37.0%) | $688.00M(+2.7%) |
Jun 2009 | - | $311.00M(+71.8%) | $670.00M(-1.6%) |
Dec 2008 | $681.00M(+25.6%) | $181.00M(+1.7%) | $681.00M(+5.1%) |
Sep 2008 | - | $178.00M(-1.1%) | $648.00M(+8.4%) |
Jun 2008 | - | $180.00M(+26.8%) | $598.00M(+13.3%) |
Mar 2008 | - | $142.00M(-4.1%) | $528.00M(-2.6%) |
Dec 2007 | $542.00M(+39.0%) | $148.00M(+15.6%) | $542.00M(+5.9%) |
Sep 2007 | - | $128.00M(+16.4%) | $511.90M(+6.3%) |
Jun 2007 | - | $110.00M(-29.5%) | $481.60M(+1.6%) |
Mar 2007 | - | $156.00M(+32.3%) | $474.00M(+21.5%) |
Dec 2006 | $390.00M(+25.8%) | $117.90M(+20.7%) | $390.00M(+9.8%) |
Sep 2006 | - | $97.70M(-4.6%) | $355.30M(+4.3%) |
Jun 2006 | - | $102.40M(+42.2%) | $340.70M(+11.8%) |
Mar 2006 | - | $72.00M(-13.5%) | $304.70M(-1.7%) |
Dec 2005 | $310.00M(-0.3%) | $83.20M(+0.1%) | $310.00M(-5.0%) |
Sep 2005 | - | $83.10M(+25.2%) | $326.20M(+2.5%) |
Jun 2005 | - | $66.40M(-14.1%) | $318.10M(-1.9%) |
Mar 2005 | - | $77.30M(-22.2%) | $324.20M(+4.2%) |
Dec 2004 | $311.00M(+49.9%) | $99.40M(+32.5%) | $311.00M(+12.4%) |
Sep 2004 | - | $75.00M(+3.4%) | $276.60M(+6.6%) |
Jun 2004 | - | $72.50M(+13.1%) | $259.50M(+10.6%) |
Mar 2004 | - | $64.10M(-1.4%) | $234.70M(+13.1%) |
Dec 2003 | $207.50M(+29.4%) | $65.00M(+12.3%) | $207.50M(+7.5%) |
Sep 2003 | - | $57.90M(+21.4%) | $193.00M(+15.1%) |
Jun 2003 | - | $47.70M(+29.3%) | $167.70M(-0.4%) |
Mar 2003 | - | $36.90M(-26.9%) | $168.30M(+4.9%) |
Dec 2002 | $160.40M(+19.6%) | $50.50M(+54.9%) | $160.40M(+4.9%) |
Sep 2002 | - | $32.60M(-32.5%) | $152.97M(+0.9%) |
Jun 2002 | - | $48.30M(+66.6%) | $151.65M(+8.6%) |
Mar 2002 | - | $29.00M(-32.7%) | $139.68M(+4.2%) |
Dec 2001 | $134.07M(+49.9%) | $43.07M(+37.7%) | $134.07M(+47.3%) |
Sep 2001 | - | $31.28M(-13.9%) | $91.00M(+52.4%) |
Jun 2001 | - | $36.34M(+55.4%) | $59.72M(+155.4%) |
Mar 2001 | - | $23.38M | $23.38M |
Dec 2000 | $89.42M(+33.3%) | - | - |
Dec 1999 | $67.07M(+22.0%) | - | - |
Dec 1998 | $54.98M(-13.3%) | - | - |
Dec 1997 | $63.40M(-53.1%) | - | - |
Dec 1996 | $135.30M(+11.2%) | - | - |
Dec 1995 | $121.70M(+35.8%) | - | - |
Dec 1994 | $89.60M(+97.8%) | - | - |
Dec 1993 | $45.30M(-7.0%) | - | - |
Dec 1992 | $48.70M(+118.4%) | - | - |
Dec 1991 | $22.30M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual capital expenditures?
- What is the all time high annual CAPEX for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual CAPEX year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly CAPEX year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM capital expenditures?
- What is the all time high TTM CAPEX for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM CAPEX year-on-year change?
What is Teva Pharmaceutical Industries Limited annual capital expenditures?
The current annual CAPEX of TEVA is $498.00M
What is the all time high annual CAPEX for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual capital expenditures is $1.10B
What is Teva Pharmaceutical Industries Limited annual CAPEX year-on-year change?
Over the past year, TEVA annual capital expenditures has changed by -$28.00M (-5.32%)
What is Teva Pharmaceutical Industries Limited quarterly capital expenditures?
The current quarterly CAPEX of TEVA is $127.00M
What is the all time high quarterly CAPEX for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly capital expenditures is $333.00M
What is Teva Pharmaceutical Industries Limited quarterly CAPEX year-on-year change?
Over the past year, TEVA quarterly capital expenditures has changed by +$3.00M (+2.42%)
What is Teva Pharmaceutical Industries Limited TTM capital expenditures?
The current TTM CAPEX of TEVA is $501.00M
What is the all time high TTM CAPEX for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM capital expenditures is $1.12B
What is Teva Pharmaceutical Industries Limited TTM CAPEX year-on-year change?
Over the past year, TEVA TTM capital expenditures has changed by -$10.00M (-1.96%)